Our strategy is to engage and support talented researchers who:
- Have a proven track record and/or high potential for high impact research in neurodegeneration
- Are dedicated to using their research to produce tangible benefits for patients
- Work collaboratively across disciplines and institutions
- Engage with other partners who are helping to accelerate our shared progress
Scientific Advisory Board
The Scientific Advisory Board (SAB) of the Tau Consortium is composed of internationally recognized experts in neurodegenerative disease research. This group provides scientific oversight and critical evaluation of research initiatives to ensure the consortium remains at the forefront of tau-related discovery and therapeutic development.
